Mithat Gönen, PhD

Chief, Biostatistics Service
Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Departmental Newsletter
Career Opportunities
Quantitative Sciences Undergraduate Research Experience (QSURE)
Genomics Experience for Master’s Students (GEMS)
Software
Bridge to Biostats Programs

Mithat Gönen, PhD

Chief, Biostatistics Service
Share
Share
Pictured: Mithat Gönen

Email

[email protected]

Education

Texas Tech University

Current Research Interest 

Dr. Gönen has been at MSK since 1999 and has been serving as Chief of the Biostatistics Service since 2015. His translational and clinical collaborations focus on genomic profiling of hematologic malignancies, surgical treatment of gastrointestinal and hepatobiliary cancers and development and evaluation of novel molecular imaging technologies. Most of Dr. Gönen’s methodological research originates from these collaborations, including building, assessing and comparing prognostic and predictive models, design and analysis of clinical trials and imaging studies, as well as Bayesian methods. He is the principal investigator of the MSK MIND Colorectal Project, and the MSK PI of the multi-center VOL-PACT project. Dr. Gönen served as co-director of the AACR/ASCO Vail Workshop on Methods in Clinical Cancer Research from 2011 to 2013 and served ASCO and AACR in numerous other roles. He is the 2021-2022 President of the Society for Clinical Trials (SCT), which he served in the past as Program Chair for the 2012 Annual Meeting, deputy editor of Clinical Trials: Journal of the Society for Clinical Trials, member of the board of directors and member of the executive committee, and the President. Dr. Gönen is a fellow of the American Statistical Association, a fellow of the SCT, a member of the board of reviewing editors for Science in Translational Medicine, and a member of the EORTC Protocol Review Committee. He served the International Biometric Society as the Program Chair for its North America meeting in 2015.

Publications

Selected peer-reviewed publications:

  1. Olshen, A.B., Garcia, A., Kapphahn, K.I., Weng, Y., Vargo, J., Pugliese, J.A., Crow, D., Wesson, P.D., Rutherford, G.W., Gönen, M., Desai, M. COVIDNearTerm: A Simple Method to Forecast COVID-19 Hospitalizations (2022) Journal of Clinical and Translational Science,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129151925&doi=10.1017%2fcts.2022.389&partnerID=40&md5=9cd840652baf202d26d92c1635c1207c DOI: 10.1017/cts.2022.389 DOCUMENT TYPE: Article SOURCE: Scopus
  2. Weiser, M.R., Hsu, M., Bauer, P.S., Chapman, W.C., Jr, González, I.A., Chatterjee, D., Lingam, D., Mutch, M.G., Keshinro, A., Shia, J., Vakiani, E., Konishi, T., Shimada, Y., Stadler, Z., Segal, N.H., Cercek, A., Saltz, L., Yaeger, R., Varghese, A., Widmar, M., Wei, I.H., Pappou, E.P., Smith, J.J., Nash, G., Paty, P., Garcia-Aguilar, J., Gönen, M. Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer(2021) Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39 (8), pp. 911-919. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102658077&doi=10.1200%2fJCO.20.02553&partnerID=40&md5=f48b15ce4a2d0187328c439d4253e87d DOI: 10.1200/JCO.20.02553 DOCUMENT TYPE: Article SOURCE: Scopus
  3. Strong, V.E., Russo, A.E., Nakauchi, M., Schattner, M., Selby, L.V., Herrera, G., Tang, L., Gönen, M.Robotic Gastrectomy for Gastric Adenocarcinoma in the USA: Insights and Oncologic Outcomes in 220 Patients(2021) Annals of Surgical Oncology, 28 (2), pp. 742-750. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087749006&doi=10.1245%2fs10434-020-08834-7&partnerID=40&md5=6c63fb7cf32e350c2afd5cbbe9638d58 DOI: 10.1245/s10434-020-08834-7 DOCUMENT TYPE: Article SOURCE: Scopus
  4. Begg, C.B., Gönen, M., Heitjan, D.F.Editorial: Clinical trial design in the era of COVID-19(2020) Clinical Trials, 17 (5), pp. 465-466.https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087746428&doi=10.1177%2f1740774520940230&partnerID=40&md5=e6d139fa684983e5bfb840d500a33d72 DOI: 10.1177/1740774520940230 DOCUMENT TYPE: Editorial SOURCE: Scopus
  5. Capanu, M., Giurcanu, M., Begg, C.B., Gönen, M. Optimized variable selection via repeated data splitting (2020) Statistics in Medicine, 39 (16), pp. 2167-2184.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083341967&doi=10.1002%2fsim.8538&partnerID=40&md5=851928f6df9e362cd60fbcc0f0987cdb DOI: 10.1002/sim.8538 DOCUMENT TYPE: Article SOURCE: Scopus  

Visit PubMed for a full listing of Mithat Gönen’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

My Downloads

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Mithat Gönen discloses the following relationships and financial interests:

  • GLG Pharmaceuticals
    Provision of Services
  • Guidepoint Global Advisors
    Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures